Last reviewed 2026-04-23 · How we verify

Live SK08 powder

Live SK08 powder is a live attenuated bacterial vaccine designed to stimulate immune responses against specific pathogens or disease targets.

Live SK08 powder is a live attenuated bacterial vaccine designed to stimulate immune responses against specific pathogens or disease targets. Used for Indication under investigation in Phase 3 (specific indication not publicly disclosed).

At a glance

Mechanism of action

As a live vaccine formulation, SK08 likely works by introducing a weakened or modified form of a pathogenic organism to prime the adaptive immune system, generating both cellular and humoral immunity. The powder formulation suggests oral or mucosal administration to establish local and systemic immune protection. The specific pathogen or therapeutic target remains proprietary to the developer.

Approved indications

• Indication under investigation in Phase 3 (specific indication not publicly disclosed)

Common side effects

• Mild gastrointestinal symptoms
• Local or systemic inflammatory response

Key clinical trials

• A Study to Evaluate the Efficacy and Safety of Live SK08 Powder in Patients With IBS-D (PHASE3)
• A Phase 2 Study to Evaluate the Efficacy and Safety of Live SK08 Powder in Adult Patients with Active Mild to Moderate Ulcerative Colitis (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

• Live SK08 powder CI brief — competitive landscape report
• Live SK08 powder updates RSS · CI watch RSS
• Guangzhou Zhiyi Biotechnology Co., Ltd. portfolio CI